Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
KMR Group is initiating a benchmarking study to assess clinical trial cost. Utilizing both its expertise in clinical trial and site performance analysis, and years of portfolio level cost evaluation for drug development, the study will examine costs from recent global clinical trials. The study will assess both the resource and expense side of running a clinical trial. The expense side will provide further insight into non-resource clinical trial costs, including the breakdown of outsourcing costs and investigator costs. Results are expected to be available in the first part of next year.
Read the full release here.